CDT Equity Inc. (CDT) vs Eiger BioPharmaceuticals, Inc. (EIGRQ)

CDT Equity Inc. and Eiger BioPharmaceuticals, Inc. are both Biotechnology companies. CDT Equity Inc. and Eiger BioPharmaceuticals, Inc. are of similar size ($2.6M and $2.4M). CDT Equity Inc. has the higher net margin (0.00% vs −475.3%) and the higher return on invested capital (−21.3% vs −3,674.6%). Across the 12 metrics below, CDT Equity Inc. leads on 8 and Eiger BioPharmaceuticals, Inc. on 4.

Valuation

Metric CDT EIGRQ Biotechnology median
P/E n/m n/m 7.88
P/S n/m 0.80 11.47
P/B n/m n/m 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales n/m 4.37 10.73
Earnings yield 167,728,033.38% (601.00%) (28.84%)
Free cash flow yield (278,822.70%) (594.47%) (23.03%)

Profitability

Metric CDT EIGRQ Biotechnology median
Gross margin — 99.85% 65.16%
Operating margin 0.00% (455.12%) 0.00%
Net margin 0.00% (475.26%) 0.00%
Free cash flow margin 0.00% (474.11%) 0.00%
Return on equity (69.68%) (367.00%) (57.72%)
Return on assets (55.16%) (94.31%) (49.22%)
Return on invested capital (21.28%) (3,674.55%) 0.00%

Growth

Metric CDT EIGRQ Biotechnology median
Revenue growth (TTM) — 16.98% 5.64%
EPS growth (last fiscal year) 98.09% 27.11% —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric CDT EIGRQ Biotechnology median
Debt to equity 0.00 (2.84) 0.00
Current ratio 0.13 0.71 4.73
Net debt to EBITDA 0.05 (0.22) 0.96

Dividend

Metric CDT EIGRQ Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric CDT EIGRQ Biotechnology median
Market cap 2.41m 2.55m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack